CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
diet, fat-restrictedbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000532
NCT00000532Phase 3Completed
CompareCT.gov

Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated May 13, 2016

In Brief

A Phase 3 clinical trial evaluating diet, fat-restricted for Cardiovascular Diseases and 7 related conditions. Completed.

Detailed Summary

To determine if the increase in low density lipoprotein (LDL) cholesterol at the time of menopause could be ameliorated or prevented by an intensive dietary intervention. Also, to prevent the increase in body weight and associated changes in insulin, glucose, blood pressure, triglycerides, and high density lipoprotein cholesterol during the peri- to postmenopausal period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Obesity, Menopause, Postmenopause
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartFeb 1, 1992
Study CompletionJan 1, 2000
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, fat-restrictedbehavioral